| Literature DB >> 33638350 |
Anne Sieben1,2,3,4, Tim Van Langenhove2,3, Yannick Vermeiren1,5, Helena Gossye3,6,7,8, Marleen Praet9, Dimitri Vanhauwaert10, Céline Cousaert11, Sebastiaan Engelborghs1,8, Robrecht Raedt2, Paul Boon2, Patrick Santens2, Peter Paul De Deyn1,3,12, Ken R Bracke13, Katia De Meulemeester4, Christine Van Broeckhoven3,14,15, Jean-Jacques Martin1, Maria Bjerke1,16.
Abstract
Hippocampal sclerosis (HS) is a common neuropathological finding and has been associated with advanced age, TDP-43 proteinopathy, and cerebrovascular pathology. We analyzed neuropathological data of an autopsy cohort of early-onset frontotemporal dementia patients. The study aimed to determine whether in this cohort HS was related to TDP-43 proteinopathy and whether additional factors could be identified. We examined the relationship between HS, proteinopathies in frontotemporal cortices and hippocampus, Alzheimer disease, cerebrovascular changes, and age. We confirmed a strong association between HS and hippocampal TDP-43, whereas there was a weaker association between HS and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Nearly all of the FTLD-TDP cases had TDP-43 pathology in the hippocampus. HS was present in all FTLD-TDP type D cases, in 50% of the FTLD-TDP A cohort and in 6% of the FTLD-TDP B cohort. Our data also showed a significant association between HS and vascular changes. We reviewed the literature on HS and discuss possible pathophysiological mechanisms between TDP-43 pathology, cerebrovascular disease, and HS. Additionally, we introduced a quantitative neuronal cell count in CA1 to objectify the semiquantitative visual appreciation of HS.Entities:
Keywords: Cerebrovascular disease; FTLD-TDP; Frontotemporal dementia; Frontotemporal lobar degeneration; Hippocampal sclerosis; TDP-43
Mesh:
Substances:
Year: 2021 PMID: 33638350 DOI: 10.1093/jnen/nlab010
Source DB: PubMed Journal: J Neuropathol Exp Neurol ISSN: 0022-3069 Impact factor: 3.685